David A. Van Echo
Impact in
- Oncology top 2%
- Cancer Treatment and Pharmacology
- Lung Cancer Research Studies
- Otorhinolaryngology top 5%
Papers in
- Oncology 40
- Cancer Treatment and Pharmacology 16
- Lung Cancer Research Studies 13
-
- Cancer therapeutics and mechanisms 20
- Co-authors
- Merrill J. Egorin (23 shared papers)Joseph Aisner (34 shared papers)Peter H. Wiernik (16 shared papers)Margaret Whitacre (14 shared papers)Ross C. Donehower (2 shared papers)Daniel D. Von Hoff (2 shared papers)R B Weiss (1 shared paper)B Leyland-Jones (1 shared paper)
- Journals
- Cancer Chemotherapy and Pharmacology (13 papers)Journal of Clinical Oncology (7 papers)Cancer (3 papers)International Journal of Radiation Oncology*Biology*Physics (3 papers)JNCI Journal of the National Cancer Institute (2 papers)
- Partner nations
- United StatesMalaysiaAustralia
In The Last Decade
David A. Van Echo
70 papers receiving 3.0k citations
David A. Van Echo's Hit Papers
Peers
Comparison fields: 5 of 117
- Oncology 1.3k
- Otorhinolaryngology 116
- Biomaterials 397
- Pathology and Forensic Medicine 348
- Dermatology 156
Countries citing papers authored by David A. Van Echo
This map shows the geographic impact of David A. Van Echo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David A. Van Echo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David A. Van Echo more than expected).
Fields of papers citing papers by David A. Van Echo
This network shows the impact of papers produced by David A. Van Echo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David A. Van Echo. The network helps show where David A. Van Echo may publish in the future.
Co-authors
The 25 scholars most cited alongside David A. Van Echo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 71 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Hypersensitivity reactions from taxol. Hit paper breakdown → | 1990 | 996 |
| 2 | Pharmacokinetics and dosage reduction of cis-diammine(1,1-cyclobutanedicarboxylato)platinum in patients with impaired renal function. | 1984 | 278 |
| 3 | 1990 | 175 | |
| 4 | Prospective validation of a pharmacologically based dosing scheme for the cis-diamminedichloroplatinum(II) analogue diamminecyclobutanedicarboxylatoplatinum. | 1985 | 165 |
| 5 | Phase I study of the orally administered butyrate prodrug, tributyrin, in patients with solid tumors. | 1998 | 137 |
| 6 | 2000 | 84 | |
| 7 | Phase I clinical and pharmacokinetic study of hexamethylene bisacetamide (NSC 95580) administered as a five-day continuous infusion. | 1987 | 69 |
| 8 | 2001 | 67 | |
| 9 | 1997 | 65 | |
| 10 | 2003 | 58 | |
| 11 | Human pharmacokinetics, excretion, and metabolism of the anthracycline antibiotic menogaril (7-OMEN, NSC 269148) and their correlation with clinical toxicities. | 1986 | 53 |
| 12 | 1983 | 52 | |
| 13 | The pharmacology of carboplatin. | 1989 | 47 |
| 14 | 2001 | 45 | |
| 15 | 1993 | 45 | |
| 16 | 1981 | 45 | |
| 17 | 1984 | 41 | |
| 18 | 1982 | 39 | |
| 19 | 1995 | 36 | |
| 20 | 1988 | 36 |
About David A. Van Echo
David A. Van Echo is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Epidemiology and Organic Chemistry, having authored 71 papers that have together received 3.2k indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (20 papers), Cancer Treatment and Pharmacology (16 papers), Lung Cancer Research Studies (13 papers), Neuroendocrine Tumor Research Advances (8 papers), Antibiotics Pharmacokinetics and Efficacy (5 papers), Lung Cancer Treatments and Mutations (5 papers), Chemotherapy-induced organ toxicity mitigation (4 papers) and Acute Lymphoblastic Leukemia research (4 papers). The work is most often cited by research in Oncology (1.3k citations), Otorhinolaryngology (116 citations), Biomaterials (397 citations), Pathology and Forensic Medicine (348 citations) and Dermatology (156 citations). David A. Van Echo has collaborated with scholars based in United States, Malaysia and Australia. Frequent co-authors include Merrill J. Egorin, Joseph Aisner, Peter H. Wiernik, Margaret Whitacre, Ross C. Donehower, Daniel D. Von Hoff, R B Weiss, B Leyland-Jones, R. Gralla and James R. Baker. Their work appears in journals such as Cancer Chemotherapy and Pharmacology, Journal of Clinical Oncology, Cancer, International Journal of Radiation Oncology*Biology*Physics and JNCI Journal of the National Cancer Institute.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.